Effects of Silver Nanoparticles on the Interactions of Neuron- and Glia-like Cells: Toxicity, Uptake Mechanisms, and Lysosomal Tracking
Overview
Toxicology
Affiliations
Silver nanoparticles (AgNPs) are commonly used nanomaterials in consumer products. Previous studies focused on its effects on neurons; however, little is known about their effects and uptake mechanisms on glial cells under normal or activated states. Here, ALT astrocyte-like, BV-2 microglia and differentiated N2a neuroblastoma cells were directly or indirectly exposed to 10 nm AgNPs using mono- and co-culture system. A lipopolysaccharide (LPS) was pretreated to activate glial cells before AgNP treatment for mimicking NP exposure under brain inflammation. From mono-culture, ALT took up the most AgNPs and had the lowest cell viability within three cells. Moreover, AgNPs induced H O and NO from ALT/activated ALT and BV-2, respectively. However, AgNPs did not induce cytokines release (IL-6, TNF-α, MCP-1). LPS-activated BV-2 took up more AgNPs than normal BV-2, while the induction of ROS and cytokines from activated cells were diminished. Ca -regulated clathrin- and caveolae-independent endocytosis and phagocytosis were involved in the AgNP uptake in ALT, which caused more rapid NP translocation to lysosome than in macropinocytosis and clathrin-dependent endocytosis-involved BV-2. AgNPs directly caused apoptosis and necrosis in N2a cells, while by indirect NP exposure to bottom chamber ALT or BV-2 in Transwell, more apoptotic upper chamber N2a cells were observed. Cell viability of BV-2 also decreased in an ALT-BV-2 co-culturing study. The damaged cells correlated to NP-mediated H O release from ALT or NO from BV-2, which indicates that toxic response of AgNPs to neurons is not direct, but indirectly arises from AgNP-induced soluble factors from other glial cells.
Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function.
Alaei M, Koushki K, Taebi K, Yousefi Taba M, Keshavarz Hedayati S, Shahbaz S RSC Adv. 2025; 15(7):5426-5451.
PMID: 39967886 PMC: 11833603. DOI: 10.1039/d4ra07798a.
Abdellatif A, Mostafa M, Konno H, Younis M 3 Biotech. 2024; 14(11):274.
PMID: 39450421 PMC: 11496425. DOI: 10.1007/s13205-024-04118-z.
Wang K, Wang S, Yin J, Yang Q, Yu Y, Chen L J Mater Sci Mater Med. 2023; 34(11):52.
PMID: 37855967 PMC: 10587321. DOI: 10.1007/s10856-023-06753-z.
An updated overview of some factors that influence the biological effects of nanoparticles.
Xuan Y, Zhang W, Zhu X, Zhang S Front Bioeng Biotechnol. 2023; 11:1254861.
PMID: 37711450 PMC: 10499358. DOI: 10.3389/fbioe.2023.1254861.
Gatti L, Chirizzi C, Rotta G, Milesi P, Sancho-Albero M, Sebastian V Nanoscale Adv. 2023; 5(14):3749-3760.
PMID: 37441254 PMC: 10334373. DOI: 10.1039/d3na00229b.